A cross-sectional study on Chinese oncology nurses’ knowledge of bone health among cancer patients

[1] Huang JF(2020)Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study Ann Transl Med 8 482-3286

[2] Shen J(2018)Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States BMC Cancer 18 44-808

[3] Li X(2013)Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems Support Care Cancer 21 3279-496

[4] Hernandez RK(2015)Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications Cancer Treat. Rev 41 798-1274

[5] Wade SW(2015)The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review BMC Cancer 15 366-3537

[6] Reich A(2013)Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases Expert Rev Pharmacoecon Outcomes Res 13 483-264

[7] Pirolli M(2020)Denosumab for cancer-related bone loss Expert Opin Biol Ther 20 1261-251

[8] Liede A(2021)Assessment of bone health education in US multiple myeloma and solid tumor patients at risk for skeletal-related events Cancer Manag Res 13 3529-226

[9] Lyman GH(2018)Cancer treatment and bone health Calcif Tissue Int 102 251-67

[10] Oster G(2017)The effectiveness of combined exercise interventions for preventing postmenopausal bone loss: a systematic review and meta-analysis J Orthop Sports Phys Ther 47 241-1162

[1] Huang JF(2020)Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study Ann Transl Med 8 482-3286

[2] Shen J(2018)Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States BMC Cancer 18 44-808

[3] Li X(2013)Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems Support Care Cancer 21 3279-496

[4] Hernandez RK(2015)Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications Cancer Treat. Rev 41 798-1274

[5] Wade SW(2015)The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review BMC Cancer 15 366-3537

[6] Reich A(2013)Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases Expert Rev Pharmacoecon Outcomes Res 13 483-264

[7] Pirolli M(2020)Denosumab for cancer-related bone loss Expert Opin Biol Ther 20 1261-251

[8] Liede A(2021)Assessment of bone health education in US multiple myeloma and solid tumor patients at risk for skeletal-related events Cancer Manag Res 13 3529-226

[9] Lyman GH(2018)Cancer treatment and bone health Calcif Tissue Int 102 251-67

[10] Oster G(2017)The effectiveness of combined exercise interventions for preventing postmenopausal bone loss: a systematic review and meta-analysis J Orthop Sports Phys Ther 47 241-1162